Clinical and economic comparison of utilization of reslizumab, mepolizumab and benralizumab in the treatment of severe eosinophilic asthma by S. K. Zyryanov, S. N. Avdeev, D. A. Ivanov, M. V. Zhuravleva, N. P. Kniajeskaia, N. V. Matveev, N. A. Nenasheva, D. S. Fomina, M. Iu. Frolov

Get full text